Skip to main content
Fig. 2 | AIDS Research and Therapy

Fig. 2

From: Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial

Fig. 2

a The graph shows the mean estimated glomerular filtration rate (eGFR) as calculated using the modification of diet in renal disease (MDRD). The bars indicate median and interquartile range change in eGFR over the 24 weeks in the lithium and placebo arms respectively. b Scatter plot of estimated glomerular filtration rate (eGFR) as calculated using the modification of diet in renal disease (MDRD) over the 24 weeks in the lithium and placebo arms respectively. The solid lines indicate the linear regression lines for the lithium and placebo arms respectively. Treatment allocation did not have a statistically significant effect on eGFR (p value 0.06)

Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us